Browse EV MemProt Atlas
Supporting publications (n)
Number of publications supporting the inclusion of this protein in EV MemProt Atlas.
EVMP confidence score
Annotation confidence score; open for threshold definitions.
Extremely high >= 0.85High >= 0.70Medium >= 0.55Low >= 0.40| UniProt ID | Protein names | Protein classification | Transmembrane count | Related Diseases | Mediation categories | Download | ||||
|---|---|---|---|---|---|---|---|---|---|---|
| MGA | O43451 | Maltase-glucoamylase (Alpha-1,4-glucosidase) (EC 3.2.1.20) | EnzymesFDA approved drug targetsMetabolic proteins | 1 | Acute diabete complicationBlood chemistry clinical symptonCardiovascular disease | Clinical-translation mediationFusion and delivery mediationImmune mediation | 0.38 | |||
| MUC17 | Q685J3 | Mucin-17 (MUC-17) (Small intestinal mucin-3) (MUC-3) | Cancer-related genesPredicted membrane proteins | 1 | Oesophagogastric junction cancerStomach cancer | Clinical-translation mediationFusion and delivery mediationImmune mediation | 0.38 | |||
| NPCL1 | Q9UHC9 | NPC1-like intracellular cholesterol transporter 1 (NPC1L1) (Niemann-Pick C1-like protein 1) | FDA approved drug targetsMetabolic proteinsPredicted membrane proteins | 13 | Hyper-lipoproteinaemia | Clinical-translation mediationFusion and delivery mediation | 0.38 | |||
| ORAI1 | Q96D31 | Calcium release-activated calcium channel protein 1 (Protein orai-1) (Transmembrane protein 142A) | Disease related genesHuman disease related genesPotential drug targets | 4 | Fusion and delivery mediationImmune mediationReceptor-signaling mediation | 0.38 | ||||
| PKD1 | P98161 | Polycystin-1 (PC1) (Autosomal dominant polycystic kidney disease 1 protein) | Disease related genesHuman disease related genesPlasma proteins | 11 | Adhesion and uptake mediationFusion and delivery mediationMetabolism mediation | 0.38 | ||||
| RAB18 | Q9NP72 | Ras-related protein Rab-18 (EC 3.6.5.2) | Cancer-related genesDisease related genesHuman disease related genes | Fusion and delivery mediationImmune mediationMetabolism mediation | 0.38 | |||||
| S12A3 | P55017 | Solute carrier family 12 member 3 (Na-Cl cotransporter) (NCC) (Na-Cl symporter) (Thiazide-sensitive sodium-chloride cotransporter) | Disease related genesFDA approved drug targetsHuman disease related genes | 12 | Essential hypertensionHypertensionOedema | Clinical-translation mediationFusion and delivery mediation | 0.38 | |||
| S20A2 | Q08357 | Sodium-dependent phosphate transporter 2 (Gibbon ape leukemia virus receptor 2) (GLVR-2) (Phosphate transporter 2) (PiT-2) (Pit2) (hPit2) (Solute carrier family 20 member 2) | Disease related genesHuman disease related genesMetabolic proteins | 12 | Clinical-translation mediationFusion and delivery mediation | 0.38 | ||||
| S22A6 | Q4U2R8 | Solute carrier family 22 member 6 (Organic anion transporter 1) (hOAT1) (PAH transporter) (hPAHT) (Renal organic anion transporter 1) (hROAT1) | FDA approved drug targetsMetabolic proteinsPredicted membrane proteins | 12 | Clinical-translation mediationFusion and delivery mediation | 0.38 | ||||
| S22A8 | Q8TCC7 | Organic anion transporter 3 (hOAT3) (Organic anion/dicarboxylate exchanger) (Solute carrier family 22 member 8) | FDA approved drug targetsMetabolic proteinsPredicted membrane proteins | 11 | GoutHerpes simplex infectionInborn purine/pyrimidine/nucleotide metabolism error | Clinical-translation mediationFusion and delivery mediation | 0.38 | |||
| S22AB | Q9NSA0 | Solute carrier family 22 member 11 (Organic anion transporter 4) (OAT4) (Organic anion:dicarboxylate exchanger OAT4) | FDA approved drug targetsMetabolic proteinsPlasma proteins | 12 | Clinical-translation mediationFusion and delivery mediation | 0.38 | ||||
| S22AC | Q96S37 | Solute carrier family 22 member 12 (Organic anion transporter 4-like protein) (Renal-specific transporter) (RST) (Urate anion exchanger 1) (URAT1) (Urate:anion antiporter SLC22A12) | Disease related genesFDA approved drug targetsHuman disease related genes | 12 | Clinical-translation mediationFusion and delivery mediation | 0.38 | ||||
| S26A4 | O43511 | Pendrin (Sodium-independent chloride/iodide transporter) (Solute carrier family 26 member 4) | Disease related genesHuman disease related genesMetabolic proteins | 12 | Clinical-translation mediationFusion and delivery mediation | 0.38 | ||||
| S6A19 | Q695T7 | Sodium-dependent neutral amino acid transporter B(0)AT1 (Solute carrier family 6 member 19) (System B(0) neutral amino acid transporter AT1) | Disease related genesHuman disease related genesMetabolic proteins | 12 | Clinical-translation mediationFusion and delivery mediation | 0.38 | ||||
| SC5A2 | P31639 | Sodium/glucose cotransporter 2 (Na(+)/glucose cotransporter 2) (Low affinity sodium-glucose cotransporter) (Solute carrier family 5 member 2) | Disease related genesFDA approved drug targetsHuman disease related genes | 14 | Clinical-translation mediationFusion and delivery mediation | 0.38 | ||||
| SNTA1 | Q13424 | Alpha-1-syntrophin (59 kDa dystrophin-associated protein A1 acidic component 1) (Pro-TGF-alpha cytoplasmic domain-interacting protein 1) (TACIP1) (Syntrophin-1) | Disease related genesHuman disease related genesPredicted intracellular proteins | Fusion and delivery mediation | 0.38 | |||||
| SUIS | P14410 | Sucrase-isomaltase, intestinal [Cleaved into: Sucrase (EC 3.2.1.48); Isomaltase (EC 3.2.1.10)] | Disease related genesEnzymesFDA approved drug targets | 1 | Clinical-translation mediationFusion and delivery mediation | 0.38 | ||||
| TBCD | Q9BTW9 | Tubulin-specific chaperone D (Beta-tubulin cofactor D) (tfcD) (SSD-1) (Tubulin-folding cofactor D) | Disease related genesEssential proteinsHuman disease related genes | Adhesion and uptake mediationFusion and delivery mediationMetabolism mediation | 0.38 | |||||
| TR10A | O00220 | Tumor necrosis factor receptor superfamily member 10A (Death receptor 4) (TNF-related apoptosis-inducing ligand receptor 1) (TRAIL receptor 1) (TRAIL-R1) (CD antigen CD261) | Cancer-related genesCD markersPredicted membrane proteins | 1 | Fusion and delivery mediationImmune mediationReceptor-signaling mediation | 0.38 | ||||
| VATE1 | P36543 | V-type proton ATPase subunit E 1 (V-ATPase subunit E 1) (V-ATPase 31 kDa subunit) (p31) (Vacuolar proton pump subunit E 1) | Disease related genesEssential proteinsHuman disease related genes | Fusion and delivery mediationImmune mediationReceptor-signaling mediation | 0.38 | |||||
| CD1D | P15813 | Antigen-presenting glycoprotein CD1d (R3G1) (CD antigen CD1d) | Cancer-related genesCD markersPredicted membrane proteins | 1 | Adhesion and uptake mediationFusion and delivery mediationImmune mediation | 5 | 0.25 | |||
| CD36 | P16671 | Platelet glycoprotein 4 (Fatty acid translocase) (FAT) (Glycoprotein IIIb) (GPIIIB) (Leukocyte differentiation antigen CD36) (PAS IV) (PAS-4) (Platelet collagen receptor) (Platelet glycoprotein IV) (GPIV) (Thrombospondin receptor) (CD antigen CD36) | Cancer-related genesCD markersDisease related genes | 2 | Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediation | 5 | 0.25 | |||
| CD59 | P13987 | CD59 glycoprotein (1F5 antigen) (20 kDa homologous restriction factor) (HRF-20) (HRF20) (MAC-inhibitory protein) (MAC-IP) (MEM43 antigen) (Membrane attack complex inhibition factor) (MACIF) (Membrane inhibitor of reactive lysis) (MIRL) (Protectin) (CD antigen CD59) | Cancer-related genesCD markersDisease related genes | Macular degenerationRetinopathy | Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediation | 5 | 0.25 | |||
| EXTL3 | O43909 | Exostosin-like 3 (EC 2.4.1.223) (EXT-related protein 1) (Glucuronyl-galactosyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase) (Hereditary multiple exostoses gene isolog) (Multiple exostosis-like protein 3) (Putative tumor suppressor protein EXTL3) | Disease related genesEnzymesHuman disease related genes | 1 | Immune mediationMetabolism mediationReceptor-signaling mediation | 5 | 0.25 | |||
| GLUT4 | P14672 | Solute carrier family 2, facilitated glucose transporter member 4 (Glucose transporter type 4, insulin-responsive) (GLUT-4) | Disease related genesMetabolic proteinsPotential drug targets | 12 | Type 2 diabetes mellitus | Clinical-translation mediationFusion and delivery mediationMetabolism mediation | 5 | 0.25 |